We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Cancer Immunology – News and Features

News

Immunovaccine Licenses Clinical Stage Cancer Vaccine from Merck KGaA

Immunovaccine will build on the current on-going Phase 1 study for EMD 640744 by formulating the survivin-based vaccine in its DepoVax™.
News

Rare Hybrid Cell Key to Regulating the Immune System

The discovery could have implications for the efficacy of new therapies that manipulate two immune cell types to treat cancer and rheumatoid arthritis.
News

Vaxon Biotech Successfully Completes its Phase I/II Trial of Vx-001 Cancer Vaccine

Results show Vx-001 vaccine to be safe, strongly immunogenic and clinically active; vaccine is now ready to move to pivotal Phase III trial.
News

Oncos Therapeutics Raises €4 Million from Healthcap to Develop Oncolytic Viruses into Cancer Treatments

Oncos has selected its modified oncolytic adenovirus CGTG-102 as its lead clinical candidate.
News

Fluidigm and Qiagen's SABiosciences Team up to Provide Over 100 PCR Gene Expression Panels for Biomark Systems

Fluidigm Corporation and SABiosciences (a QIAGEN Company) today announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis.
News

immatics Enters Collaboration with Cancer Research UK to Develop Cancer Vaccine

Cancer Research UK will sponsor and conduct a Phase I trial of IMA950 for glioblastoma.
News

Immatics Enters Collaboration with Cancer Research UK to Develop Multi-target Rationally Designed Therapeutic Cancer Vaccine

IMA950 to enter Phase I development for glioblastoma, the most aggressive form of brain cancer
News

QIAGEN Unit and Pfizer Enter Into an Agreement to Develop a Companion Diagnostic for Brain Tumor Patients

The agreement will develop a companion diagnostic test kit for PF-04948568 for the treatment of glioblastoma multiforme.
News

QIAGEN Unit and Pfizer Collaborates to Develop a Companion Diagnostic for Brain Tumor Patients

Both companies have entered into an agreement to develop a companion diagnostic test kit for PF-04948568.
News

Immutep Announces Final Results In Phase I/II Chemoimmunotherapy Trial in Breast Cancer

Results reveal that ImmuFact IMP321 doubles clinical response rate in first-line metastatic breast cancer.
Advertisement